NDC 49884-283-52 - Everolimus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49884-283
- Requested NDC
- 49884-283-52
- Package NDCs from labels
- 49884-283-52, 49884-283-02
- Manufacturer
- Par Health USA, LLC
- Effective date
- 2026-10-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Everolimus - Par Health USA, LLC | Par Health USA, LLC | 2026-10-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49884-283-02 | Everolimus | 6 in 1 CARTON | TABLET | 6 | 15 | |
| 49884-283-52 | Everolimus | 10 in 1 BLISTER PACK | TABLET | 10 | 15 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49884-283-02 | EA - Each | 49884-283 | 21072fe5-a025-41f8-ba96-feabcbed84e6 | 1 | 2022-02-07 |
| 49884-283-52 | EA - Each | 49884-283 | dbc24c01-98ee-4368-b1fe-e004de1095ac | 1 | 2022-03-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | NorthStar RxLLC | 5cfca904-b75c-5a39-8cb9-b99bb421bceb | 2024-08-02 | Warnings, Adverse reactions | 9HW64Q8G6G |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 1P9D0Z171K |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 1P9D0Z171K |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 1P9D0Z171K |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 1P9D0Z171K |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 1P9D0Z171K |
| Everolimus | EVEROLIMUS | Natco Pharma Limited | e3dbbc24-7e55-4069-a305-e2cded2db641 | 2023-06-08 | Warnings, Adverse reactions | 9HW64Q8G6G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.